136 related articles for article (PubMed ID: 37865284)
21. Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia.
Lennard L; Cartwright CS; Wade R; Richards SM; Vora A
Br J Clin Pharmacol; 2013 Jul; 76(1):125-36. PubMed ID: 23252716
[TBL] [Abstract][Full Text] [Related]
22. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.
Evans WE; Hon YY; Bomgaars L; Coutre S; Holdsworth M; Janco R; Kalwinsky D; Keller F; Khatib Z; Margolin J; Murray J; Quinn J; Ravindranath Y; Ritchey K; Roberts W; Rogers ZR; Schiff D; Steuber C; Tucci F; Kornegay N; Krynetski EY; Relling MV
J Clin Oncol; 2001 Apr; 19(8):2293-301. PubMed ID: 11304783
[TBL] [Abstract][Full Text] [Related]
23. Thiopurine S-methyltransferase pharmacogenetics: variant allele functional and comparative genomics.
Salavaggione OE; Wang L; Wiepert M; Yee VC; Weinshilboum RM
Pharmacogenet Genomics; 2005 Nov; 15(11):801-15. PubMed ID: 16220112
[TBL] [Abstract][Full Text] [Related]
24. Comparison of three methods for measuring thiopurine methyltransferase activity in red blood cells and human leukemia cells.
Karim H; Appell ML; Fotoohi A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():80-5. PubMed ID: 24113235
[TBL] [Abstract][Full Text] [Related]
25. The effect of thiopurine drugs on DNA methylation in relation to TPMT expression.
Hogarth LA; Redfern CP; Teodoridis JM; Hall AG; Anderson H; Case MC; Coulthard SA
Biochem Pharmacol; 2008 Oct; 76(8):1024-35. PubMed ID: 18708030
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in the pharmacogenomics of thiopurine methyltransferase.
Coulthard SA; Hall AG
Pharmacogenomics J; 2001; 1(4):254-61. PubMed ID: 11908768
[TBL] [Abstract][Full Text] [Related]
27. Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond.
Karas-Kuzelicki N; Mlinaric-Rascan I
Pharmacogenomics; 2009 Aug; 10(8):1309-22. PubMed ID: 19663675
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenetic studies of thiopurine methyltransferase genotype-phenotype concordance and effect of methotrexate on thiopurine metabolism.
Zimdahl Kahlin A; Helander S; Wennerstrand P; Vikingsson S; Mårtensson LG; Appell ML
Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):52-65. PubMed ID: 32865889
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of targeted disruption of thiopurine methyltransferase on mercaptopurine and thioguanine pharmacodynamics.
Hartford C; Vasquez E; Schwab M; Edick MJ; Rehg JE; Grosveld G; Pui CH; Evans WE; Relling MV
Cancer Res; 2007 May; 67(10):4965-72. PubMed ID: 17510427
[TBL] [Abstract][Full Text] [Related]
30. Are patients with intermediate TPMT activity at increased risk of myelosuppression when taking thiopurine medications?
Higgs JE; Payne K; Roberts C; Newman WG
Pharmacogenomics; 2010 Feb; 11(2):177-88. PubMed ID: 20136357
[TBL] [Abstract][Full Text] [Related]
31. Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment; a pharmacogenomic test whose time has come.
Ford LT; Berg JD
J Clin Pathol; 2010 Apr; 63(4):288-95. PubMed ID: 20354201
[TBL] [Abstract][Full Text] [Related]
32. IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations.
Haglund S; Taipalensuu J; Peterson C; Almer S
Br J Clin Pharmacol; 2008 Jan; 65(1):69-77. PubMed ID: 17662091
[TBL] [Abstract][Full Text] [Related]
33. Frequency distribution of thiopurine S-methyltransferase activity in red blood cells of a healthy Japanese population.
Kubota T; Nishida A; Takeuchi K; Iida T; Yokota H; Higashi K; Nakahara K; Hanai H; Iga T
Ther Drug Monit; 2004 Jun; 26(3):319-21. PubMed ID: 15167635
[TBL] [Abstract][Full Text] [Related]
34. Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms.
Krynetski EY; Tai HL; Yates CR; Fessing MY; Loennechen T; Schuetz JD; Relling MV; Evans WE
Pharmacogenetics; 1996 Aug; 6(4):279-90. PubMed ID: 8873214
[TBL] [Abstract][Full Text] [Related]
35. Distribution of TPMT risk alleles for thiopurine [correction of thioupurine] toxicity in the Israeli population.
Efrati E; Adler L; Krivoy N; Sprecher E
Eur J Clin Pharmacol; 2009 Mar; 65(3):257-62. PubMed ID: 19048244
[TBL] [Abstract][Full Text] [Related]
36. Association between thiopurine S-methyltransferase polymorphisms and thiopurine-induced adverse drug reactions in patients with inflammatory bowel disease: a meta-analysis.
Liu YP; Wu HY; Yang X; Xu HQ; Li YC; Shi DC; Huang JF; Huang Q; Fu WL
PLoS One; 2015; 10(3):e0121745. PubMed ID: 25799415
[TBL] [Abstract][Full Text] [Related]
37. Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia.
Dokmanovic L; Urosevic J; Janic D; Jovanovic N; Petrucev B; Tosic N; Pavlovic S
Ther Drug Monit; 2006 Dec; 28(6):800-6. PubMed ID: 17164697
[TBL] [Abstract][Full Text] [Related]
38. Thiopurine S-methyltransferase polymorphisms: efficient screening method for patients considering taking thiopurine drugs.
Wusk B; Kullak-Ublick GA; Rammert C; von Eckardstein A; Fried M; Rentsch KM
Eur J Clin Pharmacol; 2004 Mar; 60(1):5-10. PubMed ID: 14985890
[TBL] [Abstract][Full Text] [Related]
39. Differential role of thiopurine methyltransferase in the cytotoxic effects of 6-mercaptopurine and 6-thioguanine on human leukemia cells.
Karim H; Ghalali A; Lafolie P; Vitols S; Fotoohi AK
Biochem Biophys Res Commun; 2013 Jul; 437(2):280-6. PubMed ID: 23811272
[TBL] [Abstract][Full Text] [Related]
40. Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia.
Chrzanowska M; Kuehn M; Januszkiewicz-Lewandowska D; Kurzawski M; Droździk M
Acta Pol Pharm; 2012; 69(3):405-10. PubMed ID: 22594254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
